Ariti Admin

Ariti Admin

New collaboration Ariti – Oncopeptides

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announced its first named patient sales of its flagship drug Pepaxti in Greece. The sales were made possible through Oncopeptides’ partnership with Ariti S.A., a company specialized…

Ariti S.A. as Sponsor in the 13th Urological Conference of Northern Greece, 25-27 February 2022, Grand Hotel Thessaloniki. Ariti S.A. as Sponsor in the 13th Urological Conference of Northern Greece, 25-27 February 2022, Grand Hotel Thessaloniki. Ariti S.A. as Sponsor…